$Plus Therapeutics(PSTV)$ Plus Therapeutics jumps 23% premarket after obtaining a nonexclusive license and option for exclusivity for patients receiving CNS radiotherapy
| 发布于: | 雪球 | 转发：0 | 回复：0 | 喜欢：0 |
$Plus Therapeutics(PSTV)$ Plus Therapeutics jumps 23% premarket after obtaining a nonexclusive license and option for exclusivity for patients receiving CNS radiotherapy